D70.1 - Agranulocytosis secondary to cancer chemotherapy
The ICD 10 Code for Agranulocytosis secondary to cancer chemotherapy is listed as D70.1.
Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.
| ICD 10 CM Field | Value |
|---|---|
| Diagnosis Code: | D70.1
|
| Description: | Agranulocytosis secondary to cancer chemotherapy
|
| Diagnostic Related Groups
(MS-DRG v30.0) |
808 - Major Hematol/immun Diag Exc Sickle Cell Crisis & Coagul W Mcc
809 - Major Hematol/immun Diag Exc Sickle Cell Crisis & Coagul W Cc 810 - Major Hematol/immun Diag Exc Sickle Cell Crisis & Coagul W/o Cc/mcc |
| Chapter | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) |
| Block | Other disorders of blood and blood-forming organs (D70-D77) |
| Parent | D70 - Neutropenia |
| ICD-9-CM Diagnosis Codes General Equivalence Mappings (GEMS): | |
| ICD 9 Dx Code: | 288.03 - Drug induced neutropenia (approximate) |
| ICD-10-CM Siblings (same level / similar specificity) of D70.1: | |
| D70.0 - Congenital agranulocytosis | |
| D70.2 - Other drug-induced agranulocytosis | |
| D70.3 - Neutropenia due to infection | |
| D70.4 - Cyclic neutropenia | |
| D70.8 - Other neutropenia | |
| D70.9 - Neutropenia, unspecified | |